BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Pseudomonas infection
,
Hippocampus
,
rs3825942
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
marburg virus disease
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Marburg virus disease: A summary for clinicians.
Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-base…
Developing a vaccine against Marburg virus disease.
Marburg Virus Disease: Global Threat or Isolated Events?
Combination therapy protects macaques against advanced Marburg virus disease.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ebola and Marburg Virus Vaccines
Phase 2 Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults
Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
Evaluating an Ebola and a Marburg Vaccine in Uganda
Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy A…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ